Generic version of a drug already on the market, which can suppress and prevent HIV, would still yield 30% profit if the current price was slashed, researchers say
Even with PrEP distributed freely (with a prescription) HIV is still spreading. So unfortunately it’s not purely a money problem. A vaccine you only have to take yearly would dramatically change the landscape of transmission.
Even with PrEP distributed freely (with a prescription) HIV is still spreading. So unfortunately it’s not purely a money problem. A vaccine you only have to take yearly would dramatically change the landscape of transmission.
PrEP is very expensive. It is covered potentially partially by insurance.